The desire to standardize reporting and to get even more out of their oncological images led to the partnership of the Noordwest Ziekenhuisgroep in the Netherlands and Mint Medical.
Currently, mint Lesion™ is used in clinical routine in the hospital in Alkmaar: image assessment is done according to RECIST, irRECIST and PI-RADS, with TNM8 being used for colon/rectum. Dr. Remy Geenen, Head of Radiology, is very satisfied with the software solution and convinced of its benefits: “By using mint Lesion™, we are able to generate standardized, complete and consistent oncologic reports. Not only can we describe all the important aspects of a particular tumor, but we are also storing important data in the background, which can be used for quality control and science.” The structured, high-quality annotated data in mint Lesion™ can be used to augment decision-making in multidisciplinary tumor boards or draw up new hypotheses, which go beyond the published literature.
The plan is to gradually expand the use of even more templates in their clinical routine, setting a high standard for their reporting and facilitating interdisciplinary collaboration between colleagues and referring physicians. Since mint Lesion™ generates reports in a clearly structured layout, it is easy for physicians from other disciplines to directly find the information that is relevant to them. This, coupled with the fact that snapshots of findings are integrated directly into the report, leads to fewer queries and makes it possible to communicate better with patients as well.
Last month, our colleagues could finally meet up again in person with the radiologists in Alkmaar for a user training session. We look forward to further personal meetings and to our successful partnership!
High-quality annotated data in clinical routine
Related Resources
Related Resources
Heidelberg University Hospital: Key Imaging Features to Distinguish Solid Pseudopapillary Neoplasms from Pancreatic Neuroendocrine Neoplasms
Solid pseudopapillary neoplasms (SPNs), or Frantz tumors, are rare pancreatic tumors accounting for 2-3% of all pancreatic neoplasms. These tumors…
2,237 Patients, 11 Hospitals, four HCC Criteria: A Comparison Study
A recent study, conducted across 11 South Korean hospitals, compared the diagnostic performance of four hepatocellular carcinoma (HCC) diagnostic…
Multicentric Study: Comparison of Diagnostic Guidelines for Hepatocellular Carcinoma
Recent advancements in MRI techniques and tumor biology have led to updated hepatocellular carcinoma (HCC) diagnostic guidelines from various liver…